Disclosed is a cosmetic or pharmaceutical composition comprising a UV filter combination of (a) at least one benzotriazole derivative corresponding to the formula (I), wherein R1 is hydrogen； C1-C5alkyl； C1-C5alkoxy； or halogen； R2 is hydrogen； C1-C20alkyl； C1C5alkoxy； C1C5alkoxycarbonyl； C5-C10cycloalkyl； C5-C10aryl； or C5-C10aralkyl； R3 is C1C20alkyl； C5-C10cycloalkyl； C1C20alkoxy； or C5-C10cycloalkoxy； and R4 is hydrogen； or C1C5alkyl； (b) at least one UV filter selected from (b1) benzylidene malonate UV filters； (b2) micronized 5,6,5',6'-tetraphenyl-3,3'-(1,4-Phenylene)bis(1,2,4-Triazine) corresponding to the formula (b3) Benzoic acid, 4,4'-[[6-[[3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]-1 disiloxanyl]propyl]amino]-1,3,5-triazine-2,4-diyl]diimino]bis-, dibutyl ester； and (b4) 2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-methylphenyl ester； and optionally (c) at least one UV filter selected from (C1) Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine； (C2) Butyl Methoxydibenzoylmethane； (C3) Diethylhexyl Butamido Triazone； (C4) Ethylhexyl Triazone； (C5) Diethylamino Hydroxy Benzoyl Hexyl Benzoate； (C6) Ethylhexyl Methoxycinnamate； (C7) Ethylhexyl Salicylate； (C8) Homosalate； (C9) Octocrylene； (C10) Methylene Bis-Benzotriazolyl Tetramethylbutylphenol； (C11) Phenylbenzimidazole Sulfonic Acid； (C12) Titanium Dioxide； (C13) Tris-Biphenyl Triazine； (C14) (2-{4-[2-(4-Diethylamino-2-hydroxy-benzoyl)-benzoyl]-piperazine-1-carbonyl}-phenyl)-(4-diethylamino-2-hydroxy-phenyl)-methanone； (C15) merocyanine derivatives； (C16) Bis(butylbenzoate) diaminotriazine aminopropylsiloxane； and (C17) Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, encapsulated in a polymer matrix.L'invention concerne une composition cosmétique ou une composition pharmaceutique comprenant un filtre d'UV associant (a) au moins un dérivé benzotriazole de formule (I), R1 étant hydrogène； d-C5alkyle； Ci-C5alcoxy； ou halogène； R2 est hydrogène； C1-C20alkyle； C1C5alcoxy； C1C5alcoxycarbonyle； 5-C10cycloalkyle； C5
